Tasnuva Kabir

Tasnuva Kabir is a Research Fellow at the UWA Medical School and affiliated with the UWA Centre for Medical Research and the Harry Perkins Institute of Medical Research. Her work focuses on microRNA regulation in cancer biology, particularly in hepatocellular carcinoma (HCC), drug resistance mechanisms, and therapeutic strategies.

Key research interests include microRNA function in cancer progression, iron metabolism's role in metastasis, and the development of RNA-based therapies. Kabir has contributed to over 11 peer-reviewed publications, with recent work exploring miRNA-142-3p's role in overcoming drug resistance in HCC and miRNA-7's therapeutic potential in sorafenib-resistant cancer cells.

Her grants include a Department of Health (WA) project on RNA-based therapies for HCC and a Cancer Council NSW grant investigating microRNA delivery systems. Kabir's research aligns with UN Sustainable Development Goals related to health and well-being.

Notable collaborations involve institutions in Australia and international partners, reflecting her global network in oncology research. Her work has been cited over 643 times, with an h-index of 9, highlighting impactful contributions to molecular oncology and cancer therapeutics.